Connor, Clark & Lunn Investment Management (CC&L)’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $311K | Buy |
69,087
+48,017
| +228% | +$192K | ﹤0.01% | 1414 |
|
|
2025
Q4 | $80.3K | Buy |
+21,070
| New | +$81.9K | ﹤0.01% | 1490 |
|
|
2024
Q4 | – | Sell |
-23,521
| Closed | -$154K | – | 1531 |
|
|
2024
Q3 | $154K | Sell |
23,521
-311
| -1% | -$2.5K | ﹤0.01% | 1347 |
|
|
2024
Q2 | $173K | Sell |
23,832
-34,284
| -59% | -$263K | ﹤0.01% | 1275 |
|
|
2024
Q1 | $441K | Buy |
+58,116
| New | +$453K | ﹤0.01% | 1149 |
|
|
2023
Q4 | – | Sell |
-21,835
| Closed | -$86.2K | – | 1486 |
|
|
2023
Q3 | $86.2K | Sell |
21,835
-26,239
| -55% | -$99.2K | ﹤0.01% | 1303 |
|
|
2023
Q2 | $150K | Buy |
48,074
+6,227
| +15% | +$25.4K | ﹤0.01% | 1222 |
|
|
2023
Q1 | $190K | Buy |
41,847
+4,362
| +12% | +$22.8K | ﹤0.01% | 1105 |
|
|
2022
Q4 | $155K | Buy |
37,485
+24,420
| +187% | +$83.3K | ﹤0.01% | 1082 |
|
|
2022
Q3 | $42K | Buy |
+13,065
| New | +$32.7K | ﹤0.01% | 1069 |
|
|
2019
Q3 | – | Sell |
-9,889
| Closed | -$141K | – | 1031 |
|
|
2019
Q2 | $141K | Sell |
9,889
-10,952
| -53% | -$292K | ﹤0.01% | 934 |
|
|
2019
Q1 | $685K | Buy |
20,841
+296
| +1% | +$15.2K | ﹤0.01% | 608 |
|
|
2018
Q4 | $1.22M | Buy |
20,545
+1,385
| +7% | +$137K | 0.01% | 511 |
|
|
2018
Q3 | $2.69M | Buy |
19,160
+3,158
| +20% | +$383K | 0.02% | 397 |
|
|
2018
Q2 | $1.96M | Buy |
16,002
+1,233
| +8% | +$105K | 0.01% | 480 |
|
|
2018
Q1 | $1.32M | Buy |
14,769
+959
| +7% | +$81.3K | 0.01% | 448 |
|
|
2017
Q4 | $766K | Hold |
13,810
| – | – | ﹤0.01% | 558 |
|
|
2017
Q3 | $583K | Hold |
13,810
| – | – | ﹤0.01% | 614 |
|
|
2017
Q2 | $582K | Buy |
13,810
+2,091
| +18% | +$107K | ﹤0.01% | 577 |
|
|
2017
Q1 | $655K | Buy |
11,719
+2,244
| +24% | +$111K | ﹤0.01% | 578 |
|
|
2016
Q4 | $362K | Buy |
9,475
+1,031
| +12% | +$41.8K | ﹤0.01% | 677 |
|
|
2016
Q3 | $335K | Buy |
8,444
+1,992
| +31% | +$90.5K | ﹤0.01% | 651 |
|
|
2016
Q2 | $464K | Buy |
6,452
+1,442
| +29% | +$114K | ﹤0.01% | 594 |
|
|
2016
Q1 | $402K | Buy |
5,010
+608
| +14% | +$48K | ﹤0.01% | 601 |
|
|
2015
Q4 | $332K | Buy |
4,402
+3,510
| +393% | +$564K | ﹤0.01% | 610 |
|
|
2015
Q3 | $342K | Buy |
+892
| New | +$402K | ﹤0.01% | 579 |
|
Other funds holding LRMR
DM
BOCH
ACM
DCM
VCM
DCM
DTC